-
-
-
-
-
-
-
Bicara Therapeutics Inc (BCAX) PT Raised to $35 at Wedbush
-
-
-
-
-
-
-
Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens After Q1 Results
-
-
-
-
-
-
-
BofA Securities Starts Bicara Therapeutics Inc (BCAX) at Buy
-
-
-
-
-
-
-
BTIG Starts Bicara Therapeutics Inc (BCAX) at Buy
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Bicara Therapeutics Inc (BCAX)
-
-
-
-
-
-
-
Relay Therapeutics (RLAY) appoints Claire Mazumdar to Board
-
-
-
-
-
-
-
TD Cowen: 'Risk/Reward for Bicara Therapeutics Inc (BCAX) into ASCO is Great'
-
460,612 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

